Finanse publiczne · 28/07/2014
IRS Issues Temporary Regulations for Branded Prescription Drug Fee
The Internal Revenue Service (IRS) has published temporary regulations modifying the definition of controlled group for the branded prescription drug fee, affecting manufacturers and importers of certain branded prescription drugs, as part of the Patient Protection and Affordable Care Act (ACA).